BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Increased ring fractures with vaginal rings

Active substance: ethinylestradiol/etonogestrel

The BfArM has received a large number of reports of breaks in the vaginal rings GinoRing® (Exeltis Germany GmbH), Cyclelle® (Hexal AG), VeriAristo® (Aristo Pharma GmbH) and Setlona® (Mylan Germany GmbH), which are used for hormonal contraception. These reports indicate a quality defect.

To the risk information (available in German only)